Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged logo

Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged (NVOH)

Market Closed
11 Aug, 20:00
ARCA ARCA
$
25. 51
-0.13
-0.5106%
$
2.15M Market Cap
0.93% Div Yield
662 Volume
$ 25.64
Previous Close
Add Transaction
Day Range
25.51 25.66
Year Range
19 34.36
Want to track NVOH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NVOH closed today lower at $25.51, a decrease of -0.5106% from yesterday's close, completing a monthly decrease of -2.9741% or -$0.78. Over the past 12 months, NVOH stock lost -8.0789%.
NVOH pays dividends to its shareholders, with the most recent payment made on Jun 23, 2026. The next estimated payment will be in In 1 month on Sep 23, 2026 for a total of $0.767.
The stock of the company had never split.
The company's stock is traded on one exchange.

NVOH Chart

People also search for

Direxion Daily Biotech Top 5 Bull 2X ETF
$ 38.22
+0.3922%
Newday Ocean Health ETF
$ 24.33
-0.0702%
BiomX Inc.
$ 0.04
-4.1893%

Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged (NVOH) FAQ

What is the stock price today?

The current price is $25.51.

On which exchange is it traded?

Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged is listed on ARCA.

What is its stock symbol?

The ticker symbol is NVOH.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.93%.

What is its market cap?

As of today, the market cap is 2.15M.

Has Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged ever had a stock split?

No, there has never been a stock split.

Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged Profile

ARCA Exchange
US Country

Overview

The company specializes in investment strategies that focus primarily on American Depositary Receipts (ADRs) for Novo Nordisk A/S (B Shares). Under typical market conditions, the investment series commits at least 95% of its net assets to these ADRs. It's important to note that the fund does not make direct investments in Novo Nordisk itself and operates as a non-diversified fund, meaning its holdings are concentrated in fewer securities rather than being spread across a wide array of investments.

Products and Services

  • Investment in ADRs

    The primary service offered is investing in American Depositary Receipts (ADRs) of Novo Nordisk A/S (B Shares). This approach allows investors to gain exposure to the shares of Novo Nordisk while primarily trading in ADR format, which can simplify the logistics of international trading and ownership.

  • Non-Diversified Fund Structure

    The fund’s non-diversified structure enables focused investments in Novo Nordisk, creating potential for higher growth by not spreading assets over a wide range of companies. This concentrated investment strategy is designed for investors who have a strong belief in the performance of Novo Nordisk and prefer to capitalize on that singular opportunity.

Contact Information

Address: 301 South State Street, Suite N-002
Phone: 908-781-0560